Zhejiang Cheng Yi Pharmaceutical Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 603811?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	3,525,900	1.08%
Institutions	31,900,485	9.75%
Individual Insiders	130,418,094	39.8%
General Public	161,459,841	49.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 50.54% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
23.6%	Yi Yi Yan	77,192,080	CN¥624.5m	0%	no data
4.66%	National Council for Social Security Fund	15,250,320	CN¥123.4m	0%	0.02%
2.46%	Jun Da Cen	8,067,360	CN¥65.3m	0%	no data
2.25%	Ze Hui Ke	7,375,872	CN¥59.7m	0%	no data
2.1%	Yankai Xia	6,884,220	CN¥55.7m	0%	no data
1.76%	Bing Jun Ren	5,762,455	CN¥46.6m	0%	no data
1.67%	Ai Shen	5,475,006	CN¥44.3m	-11.3%	no data
1.65%	Xiao Zhuang	5,416,400	CN¥43.8m	-1.62%	no data
1.59%	Mao Lin Yan	5,218,649	CN¥42.2m	0%	no data
1.53%	China Post & Capital Fund Management Co., Ltd.	5,000,000	CN¥40.4m	0%	0.26%
1.1%	China International Capital Corporation Hong Kong Asset Management Limited	3,612,104	CN¥29.2m	-4.03%	0.15%
1.08%	Wenzhou Dongtou District Chengyi Small Loan Co., Ltd.	3,525,900	CN¥28.5m	0%	no data
0.82%	Ke Qiu	2,672,320	CN¥21.6m	0%	no data
0.7%	Shi Sheng Li	2,304,960	CN¥18.6m	0%	no data
0.7%	Zhi Hong Zhang	2,304,960	CN¥18.6m	0%	no data
0.6%	Rongtong Fund Management Co. Ltd.	1,980,000	CN¥16.0m	0%	0.05%
0.54%	Great Wall Fund Management Co., Ltd	1,769,980	CN¥14.3m	0%	0.05%
0.48%	China Merchants Fund Management Company Ltd.	1,565,890	CN¥12.7m	0%	0.01%
0.4%	Sun Zhan Lu	1,296,540	CN¥10.5m	0%	no data
0.3%	China Southern Asset Management Co., Ltd.	972,940	CN¥7.9m	0%	no data
0.18%	Gfund Management Co., Ltd.	590,740	CN¥4.8m	0%	0.02%
0.14%	Huanqun Zeng	447,272	CN¥3.6m	0%	no data
0.11%	Everbright Pramerica Fund Management Co. Ltd.	372,700	CN¥3.0m	0%	0.03%
0.075%	Bank of China Investment Management Co., Ltd.	246,200	CN¥2.0m	0%	0.01%
0.037%	Wanjia Asset Management Co., Ltd.	121,400	CN¥982.1k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/20 04:57
End of Day Share Price	2024/12/20 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Zhejiang Cheng Yi Pharmaceutical Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution